News

July 18, 2017

“Recognizing Sepsis as a Global Health Priority — A WHO Resolution” in the New England Journal of Medicine


On June 29, 2017, the prestigious New England Journal of Medicine published an article detailing the Global Sepsis Alliance’s (GSA) perspective on the World Health Organization (WHO) resolution on improving the prevention, diagnosis, and management of sepsis. 

 
July 11, 2017

Focus on sepsis

Shahrzad Kiavash was anesthetized for almost 2 weeks and stayed in the hospital for seven months. Both her lower legs were amputated. Sepsis almost cost her life. Today, Shahrzad Kiavash competes in triathlon – where swimming, cycling and running are all included in the same race. 

 
June 21, 2017

Lund researchers awarded prestigious Global Sepsis Award

Every year 40 000 Swedes suffer from sepsis, with mortality rates as high as 20 percent. Even though the disease is almost as common as cancer, few Swedes have ever heard of it. 
May 30, 2017

The World Health Organization adopts resolution to fight sepsis

On 26 May 2017, the World Health Organization (WHO) agreed on a resolution to improve the prevention, diagnosis and treatment of sepsis. The resolution urges governments to strengthen their policies in infection prevention and to decrease the spread of antimicrobial resistance. 

 
May 24, 2017

The World Health Assembly Side Event on Sepsis


The World Health Assembly Side Event on Sepsis will take place on May 24th in Geneva. It will be jointly hosted by the Global Sepsis Alliance, the German Ministry of Health and the International Alliance of Patients’ Organizations. This event is taking place on the occasion of the 70th World Health Assembly passing a resolution on sepsis, which was unanimously recommend by the WHO Executive Board. The World Health Assembly is the decision-making body of WHO. 
 
May 19, 2017

Explosion at Chinese antibiotics factory leaves a shortage of lifesaving antibiotics


There is currently a global shortage of last resort antibiotics due to a factory explosion in China a few months ago. The factory was one of the few that produces the raw materials for piperacillin / tazobactam, a kind of antibiotic given to hospitalized patients with severe infections, including sepsis. The occurrence of this global shortage highlights the fact that Sweden and other countries need to rethink their procurement policies for antibiotics.  
 
May 05, 2017

Bactiguard attends the International Sepsis Forum in Sao Paolo, Brazil.


Bactiguard and Biodina are currently attending the 14th International Sepsis Forum organized by the Latin American Sepsis Institute being held in Sao Paolo, Brazil on May 4 – 5 2017. 
 
April 19, 2017

Bactiguard sponsors FTS (Companies Together against Sexual Abuse of Children)


Bactiguard is not only committed to improving quality of life for patients but also for local communities, including in Botkyrka, where our headquarters are based. 

 
April 13, 2017

QA Director, Bactiguard AB


Do you want to be part of an international team dedicated to developing innovative healthcare products for a future more secure patient care? Bactiguard is in a strong expansion phase and we are experiencing an increasing interest in our unique technology for infection prevention, particularly in light of rapidly increasing antibiotic resistance. We are now looking for a Global QA Director. You will become part of a highly skilled team of a company in growth. This position is located at our newly built head offices near Karolinska University Hospital, Huddinge.
 
March 31, 2017

Bactiguard sponsors World Sepsis Day

Bactiguard is now a proud sponsor of World Sepsis Day initiated by the Global Sepsis Alliance. Sepsis is the main cause of death from infection and affects more than 30 million people a year; of whom 6 to 8 million die. In Sweden, almost 40,000 people suffer from sepsis per year.[1] Surviving patients suffer from the consequences for the rest of their lives.
 
 

Pages